NCT06974110 2026-01-16
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
Jiangsu Cancer Institute & Hospital
Fundación Sociedad Española de Oncologia Médica
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Chinese PLA General Hospital